These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

583 related articles for article (PubMed ID: 15812243)

  • 21. I105V polymorphism and promoter methylation of the GSTP1 gene in prostate adenocarcinoma.
    Jerónimo C; Varzim G; Henrique R; Oliveira J; Bento MJ; Silva C; Lopes C; Sidransky D
    Cancer Epidemiol Biomarkers Prev; 2002 May; 11(5):445-50. PubMed ID: 12010858
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CpG hypermethylation of MDR1 gene contributes to the pathogenesis and progression of human prostate cancer.
    Enokida H; Shiina H; Igawa M; Ogishima T; Kawakami T; Bassett WW; Anast JW; Li LC; Urakami S; Terashima M; Verma M; Kawahara M; Nakagawa M; Kane CJ; Carroll PR; Dahiya R
    Cancer Res; 2004 Sep; 64(17):5956-62. PubMed ID: 15342374
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Loss of 14-3-3sigma in prostate cancer and its precursors.
    Cheng L; Pan CX; Zhang JT; Zhang S; Kinch MS; Li L; Baldridge LA; Wade C; Hu Z; Koch MO; Ulbright TM; Eble JN
    Clin Cancer Res; 2004 May; 10(9):3064-8. PubMed ID: 15131044
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Methylation of the ASC gene promoter is associated with aggressive prostate cancer.
    Collard RL; Harya NS; Monzon FA; Maier CE; O'Keefe DS
    Prostate; 2006 May; 66(7):687-95. PubMed ID: 16425203
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Downregulation of 14-3-3sigma in ovary, prostate and endometrial carcinomas is associated with CpG island methylation.
    Mhawech P; Benz A; Cerato C; Greloz V; Assaly M; Desmond JC; Koeffler HP; Lodygin D; Hermeking H; Herrmann F; Schwaller J
    Mod Pathol; 2005 Mar; 18(3):340-8. PubMed ID: 15257317
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epigenetic regulation of MDR1 gene through post-translational histone modifications in prostate cancer.
    Henrique R; Oliveira AI; Costa VL; Baptista T; Martins AT; Morais A; Oliveira J; Jerónimo C
    BMC Genomics; 2013 Dec; 14():898. PubMed ID: 24344919
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aberrant cellular retinol binding protein 1 (CRBP1) gene expression and promoter methylation in prostate cancer.
    Jerónimo C; Henrique R; Oliveira J; Lobo F; Pais I; Teixeira MR; Lopes C
    J Clin Pathol; 2004 Aug; 57(8):872-6. PubMed ID: 15280411
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aberrant stratifin overexpression is regulated by tumor-associated CpG demethylation in lung adenocarcinoma.
    Shiba-Ishii A; Noguchi M
    Am J Pathol; 2012 Apr; 180(4):1653-62. PubMed ID: 22310466
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epigenetic events, remodelling enzymes and their relationship to chromatin organization in prostatic intraepithelial neoplasia and prostatic adenocarcinoma.
    Mohamed MA; Greif PA; Diamond J; Sharaf O; Maxwell P; Montironi R; Young RA; Hamilton PW
    BJU Int; 2007 Apr; 99(4):908-15. PubMed ID: 17378849
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CG island methylation changes near the GSTP1 gene in prostatic intraepithelial neoplasia.
    Brooks JD; Weinstein M; Lin X; Sun Y; Pin SS; Bova GS; Epstein JI; Isaacs WB; Nelson WG
    Cancer Epidemiol Biomarkers Prev; 1998 Jun; 7(6):531-6. PubMed ID: 9641498
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Promoter hypermethylation of the 14-3-3 sigma, SYK and CAGE-1 genes is related to the various phenotypes of urinary bladder carcinomas and associated with progression of transitional cell carcinomas.
    Kunze E; Wendt M; Schlott T
    Int J Mol Med; 2006 Oct; 18(4):547-57. PubMed ID: 16964403
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of glutathione-S-transferase P1 hypermethylation in molecular detection of prostate cancer.
    Hashad DI; Hashad MM; Talaat IM; Ibrahim MA
    Genet Test Mol Biomarkers; 2011 Oct; 15(10):667-70. PubMed ID: 21631298
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sensitizing hormone-refractory prostate cancer cells to drug treatment by targeting 14-3-3sigma.
    Han B; Xie H; Chen Q; Zhang JT
    Mol Cancer Ther; 2006 Apr; 5(4):903-12. PubMed ID: 16648560
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression analysis of thrombospondin 2 in prostate cancer and benign prostatic hyperplasia.
    Matos AR; Coutinho-Camillo CM; Thuler LC; Fonseca FP; Soares FA; Silva EA; Gimba ER
    Exp Mol Pathol; 2013 Jun; 94(3):438-44. PubMed ID: 23470460
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of epigenetic inactivation of 14-3-3sigma in human cancer.
    Lodygin D; Hermeking H
    Cell Res; 2005 Apr; 15(4):237-46. PubMed ID: 15857578
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MicroRNA alteration and putative target genes in high-grade prostatic intraepithelial neoplasia and prostate cancer: STAT3 and ZEB1 are upregulated during prostate carcinogenesis.
    Cha YJ; Lee JH; Han HH; Kim BG; Kang S; Choi YD; Cho NH
    Prostate; 2016 Jul; 76(10):937-47. PubMed ID: 27017949
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epigenetic regulation of the KAI1 metastasis suppressor gene in human prostate cancer cell lines.
    Sekita N; Suzuki H; Ichikawa T; Kito H; Akakura K; Igarashi T; Nakayama T; Watanabe M; Shiraishi T; Toyota M; Yoshie O; Ito H
    Jpn J Cancer Res; 2001 Sep; 92(9):947-51. PubMed ID: 11572762
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Methylation of Integrin α4 and E-Cadherin Genes in Human Prostate Cancer.
    Mostafavi-Pour Z; Kianpour S; Dehghani M; Mokarram P; Torabinejad S; Monabati A
    Pathol Oncol Res; 2015 Sep; 21(4):921-7. PubMed ID: 25743258
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In silico mining identifies IGFBP3 as a novel target of methylation in prostate cancer.
    Perry AS; Loftus B; Moroose R; Lynch TH; Hollywood D; Watson RW; Woodson K; Lawler M
    Br J Cancer; 2007 May; 96(10):1587-94. PubMed ID: 17453001
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adiponectin as a potential tumor suppressor inhibiting epithelial-to-mesenchymal transition but frequently silenced in prostate cancer by promoter methylation.
    Tan W; Wang L; Ma Q; Qi M; Lu N; Zhang L; Han B
    Prostate; 2015 Aug; 75(11):1197-205. PubMed ID: 25877612
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.